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Abstract
Background: Malaria continues to be a global public health challenge, particularly in developing countries. Delivery of
prompt and effective diagnosis and treatment of malaria cases, detection of malaria epidemics within one week of
onset and control them in less than a month, regular disease monitoring and operational classification of malaria are
among the major responsibilities of the national malaria programme. The study was conducted to determine these
indicators at the different level of primary health care facilities in malaria-affected provinces of Iran
Methods: In this survey, data was collected from 223 health facilities including health centres, malaria posts, health
houses and hospitals as well as the profile of all 5, 836 recorded malaria cases in these facilities during the year
preceding the survey. Descriptive statistics (i.e. frequencies, percentages) were used to summarize the results and
Chi square test was used to analyse data.
Results: All but one percent of uncomplicated cases took appropriate and correctly-dosed of anti-malarial drugs in
accordance to the national treatment guideline. A larger proportion of patients [85.8%; 95% CI: 84.8 - 86.8] were
also given complete treatment including anti-relapse course, in line with national guidelines. About one third
[35.0%; 95% CI: 33.6 - 36.4] of uncomplicated malaria cases were treated more than 48 hours after first symptoms
onset. Correspondingly, half of severe malaria cases took recommended anti-malarial drugs for severe or
complicated disease more than 48 hours of onset of first symptoms. The latter cases had given regular anti-malarial
drugs promptly.
The majority of malaria epidemics [97%; 95% CI: 90.6 - 100] in study areas were detected within one week of
onset, but only half of epidemics were controlled within four weeks of detection. Just half of target districts had at
least one health facility/emergency site with adequate supply and equipment stocks. Nevertheless, only one-third
of them [33% (95% CI: 0.00 - 67.8)] had updated inventory of malaria foci on quarterly basis.
Conclusion: To sum up, malaria case management still constitutes a public health problem in Iran. Additionally,
data suggest scarcity in management and evaluation of malaria foci, detection and control of malaria epidemics as
well as assignment of emergency sites across different regions of the country. Consequently, massive and
substantial investments need to be made at the Ministry of Health to coordinate national malaria control
programmes towards achieving determined goals and targets.
Background
Malaria is a global public health challenge, with about
one million deaths each year and a further 250 million
new cases of malaria diagnosed annually [1-3]. Interest-
ingly, malaria have been distributed disproportionately
such that the poorest countries in sub-Saharan Africa
bearing about 85% of the burden of malaria morbidity
and mortality in the world [1-3]. However, more than
half of the populations of the Eastern Mediterranean
Region are at potential risk of contracting malaria [1-3].
The Islamic Republic of Iran is one of the countries
located in the Eastern Mediterranean Region with low
malaria endemicity, with some regions having a reported
API ranged from 0.14 to 8.74 per 1, 000 [3-6]. The
south-eastern areas of Iran, including Sistan & Baluche-
stan (S&B), Hormozgan and the tropical part of Kerman
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provinces accounting for around 95% of all malaria
cases in the country [4-6].
The Ministry of Health and Medical Education in Iran
has focused its effort on recommended guidelines by
World Health Organization (WHO) [7-9]. These strate-
gies consist of early diagnosis and prompt effective anti-
malarial treatment; detection of malaria epidemics
within one week of onset and have it controlled in less
than a month; operational classification of malaria foci
on quarterly basis. Additionally, it is advised to assign
emergency sites and provide them with adequate supply
(i.e. spray pumps, thermal fogger machine both portable
and vehicle mounted, insecticides for indoor residual
spraying, insecticide for space spraying, insecticide-trea-
ted nets, anti-malarial drugs, rapid diagnostic tests, lan-
cet, plain slide, alcohol pad, cotton, slide box, stationery)
for urgent situation, such as outbreaks.
However, to date no comprehensive national malaria
survey has been conducted to identify the coverage of
these strategies in Iran. Additionally, the existing evi-
dence about malaria indicators in the country, which
has come mainly from routine surveillance data, is not
sufficient to measure progress towards achieving
national and regional goals and targets properly. There-
fore, the present study was conducted to determine
malaria indicators at the levels of health-treatment units
and district health facilities and to investigate the quality
of treatment of malaria cases in 20 malaria-affected dis-
tricts in the three above-mentioned regions.
Methods
Sample design
Details of sampling methods have been described else-
where [10]. Briefly, a comprehensive baseline survey
conducted in Iran to evaluate malaria indicators in two
levels: households and health facilities. The south-east-
ern provinces of Iran including 60% of the total popu-
lation of S & B, the whole population of Hormozgan
and 30% of the total population of Kerman provinces
are considered as malaria endemic regions in Iran.
These malarious regions with a population of about
three million people formed the study population dis-
tributed in S&B, Hormozgan and Kerman provinces
with an approximate proportion of 40%, 40% and 20%,
respectively.
In a multistage random sampling, 125 clusters with an
average size of 40 households were selected randomly
from the study population. Firstly, sample size was
divided based on the proportion of population in the
three target provinces. Furthermore, since each province
is, in turn, administratively subdivided into several dis-
tricts and each district includes several rural and urban
areas, the sample size of each province was divided
based on the proportion of population in rural and
urban areas. Secondly, all the health centers/units in the
target districts in the three mentioned provinces were
listed based on geographical regions and separately for
urban and rural and then the populations were calcu-
lated cumulatively. At this stage, clusters and head-clus-
ters (the first selected household as opening point for
survey) were determined using systematic random sam-
pling method. After that, trained personnel referred to
the first household in every cluster and moved on their
right side to cover the entire forty households in every
cluster. Household information has been reported in a
previously published article on malaria indicators at
household level [10].
The survey also collected information from all health
facilities in which at least one household had been
selected for this study. Consequently, the profile of 5,
836 recorded malaria cases within included health facil-
ities during the year preceding the survey were reviewed
and data were extracted to evaluate malaria diagnosis
and treatment. Furthermore, all the target district health
centres were censuses to estimate malaria indicators at
district level or health centres. Having this approach,
data were collected from 223 health facilities in both
rural and urban area of malaria endemic regions in Iran
distributed in S & B, Hormozgan and Kerman provinces.
Survey questionnaires
Three questionnaires were used for this part of survey:
the health-caring units, patients’ information in the
health care services, and malaria indicators in district
health centres. After investigating similar studies in
other parts of the world [11-15] and also reviewing
available questionnaires on the website of WHO
[16-18], the organizers of this survey developed the
questionnaires for the local situation and their comple-
tion instructions. Then questionnaires were pre-tested
in the field and their results were discussed in several
meetings. Afterwards, the questionnaires and their com-
pletion instructions were revised carefully to fulfill pur-
pose of study. Finally, a meeting was held with the
participation of the national programme manager for
malaria, malaria project manager for round seven Global
Fund malaria project, main investigators, a group of
knowledgeable malaria experts from all three provinces.
In this meeting, the contents of questionnaires were
reviewed item by item and modified, if necessary. Then
all the questionnaires and their completion instructions
were finalized for the survey. Data were collected by
trained health professionals.
Data management and analysis
Data for malaria cases, health-treatment services and
district health centres were gathered by teams of well-
qualified data collectors through direct referring to the
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selected health facilities and filling in questionnaires,
and checklists. Each team of data collectors comprised
one health professional, one laboratory technician and
team supervisor who were experienced and familiar with
the basic concepts, objectives and technical terms of the
project as well as one driver. Once all the information
was collected and entered to the software of SPSS (Ver-
sion 15) by trained data operators, analysis was done
and descriptive statistics (i.e. frequencies, percentages)
were used to estimate malaria indicators. Point estimates
and 95% confidence intervals were estimated for all indi-
cators. Relevant parametric or non-parametric statistical
test, such as Pearson’s Chi square test was used to
determine association with a probability of committing a
type 1 error (a) was set at 0.05.
Evaluation the quality of project implementation
The quality of data collection was supervised and moni-
tored daily by main investigators, provincial and district
focal points during implementation of the project to
ensure the quality and quantity of data collected by data
collectors. Additionally, the quality of data entering was
also monitored in two stages: in the primary stage, data
file and its manual was prepared by skilled experts in
statistics (MM & AAM). Then, data was entered by a
team of trained data entry operators under the direct
supervision of specialists in statistics and epidemiology
(MM, AAM & AH). In the final stage, as data was ana-
lysed the information about every variable was con-
trolled once more and if necessary was corrected by
referring to the questionnaires.
Ethical clearance
This study was approved by the research ethics commit-
tee of Zahedan University of Medical Sciences, Iran.
Results
Characteristics of study units
Data were collected from all 223 health facilities located
in the selected districts to estimate health facility-based
indicators, including detection and control of epidemics,
management and evaluation of malaria foci and service
delivery. Additionally, data were extracted from the pro-
file of 5, 836 recorded malaria cases in aforementioned
health centres during the year preceding the survey.
Malaria case management
Generally, all but one percent of uncomplicated cases
took appropriate and correctly-dosed of anti-malarial
drugs in accordance to the national treatment guide-
lines. There is also evidence that a larger proportion of
patients [85.8%; 95% CI: 84.8 - 86.8] were given com-
plete treatment including anti-relapse course, in line
with national guidelines whereas the remaining cases
(14.2%) did not take anti-relapse course because either
of immigration, or being less than five years of age or
pregnancy that is primaquine is contraindicated.
However, approximately two-third of uncomplicated
(Figure 1) and half of severe (Figure 2) malaria cases
were treated promptly on the same day or next day of
1st symptoms onset. It should be noted that all severe
cases had given regular anti-malarial drugs promptly.
Time interval between lab diagnosis and treatment were
less than 24 hours for all reviewed malaria cases.
Notably, malaria patients both uncomplicated (Figure
1) and severe (Figure 2) cases in rural areas were more
likely to receive medical attention and take an anti-
malarial drug within 24 to 48 hours of disease onset (P
for heterogeneity = 0.001). Apparently, two-third of
uncomplicated and 83.3% (95% CI: 62.3% - 100%) of
severe cases in urban areas of target districts sought
medical attention and anti-malarial drug after 48 hours
of 1st symptoms onset. Subgroup analyses also suggest
discrepancy in time interval between onset of symptoms
and laboratory diagnosis/treatment of malaria patients
across three surveyed provinces. Prompt treatment with
anti-malarial drugs was highest for both uncomplicated
and severe malaria cases in S&B region. On the con-
trary, treatment with anti-malarial drugs for uncompli-
cated patients in Kerman and severe in Hormozgan
tended to be delayed.
Malaria relapse history and mortality
There was no evidence of death due to malaria in the
year preceding the survey. However, according to these
findings, less than 10% of patients had a history of
malaria relapse due to vivax malaria.
Detection and control of epidemics
During the year preceding the survey, 42 malaria epi-
demics occurred in the country. Majority of these out-
breaks happened in S& B province. Lack of detailed data
regarding 11 epidemics precludes estimation of indica-
tors on all recorded epidemics. Therefore, analysis was
restricted on remaining 31 epidemics with adequate
data. 97% of the epidemics (95% CI: 90.6 - 100)] in tar-
get districts detected within one week of onset by health
staff. However, only half of them were controlled within
four weeks of detection (Figure 3).
Emergency sites with adequate supply and equipment
Generally speaking, there was no sufficient data to have
a good judgment about the aforementioned indicators.
However, 10 out of 21 sampled health centres [48%:
(95% CI; 17.0 - 79.0)] had at least one assigned small
emergency site with adequate supply and equipment
stock to be used in outbreaks (Figure 3). Just in one dis-
trict (Ghaleh-Ganj in Kerman); two emergency sites
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Figure 1 Time interval between onset of symptoms and treatment of uncomplicated malaria cases.
Figure 2 Time interval between onset of symptoms and treatment of severe malaria cases.
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were identified to deal with outbreaks. Additionally, data
suggest inconsistency in assignment of emergency sites
across three provinces. Number of districts with at least
one identified emergency sites were drastically higher in
Kerman (100%) compared to the Hormozgan [44.4%
(95% CI: 12.0 - 76.9) or S&B (0.0%) province.
Management and evaluation of malaria foci
Only one-third of target districts [33% (95% CI: 0.00 -
67.8)] had updated inventory of malaria foci on quar-
terly basis (Figure 3). Furthermore, data shows that
health centres in S&B or Kerman region [50% (95% CI:
10.0 - 90.0)] were more likely to make an inventory of
malaria foci than those in Hormozgan [11.1 (95% CI:
0.00 - 100.0)].
Discussion
This first comprehensive assessment of the coverage of
the key malaria indicators at the level of health facilities
in Iran highlights several important issues that need to
be addressed urgently by Ministry of Health and Medi-
cal Education to achieve malaria control targets set by
RBM partnership and Global Malaria Programme
(GMP).
One of the specific measures to be applied in order to
achieve malaria elimination is reducing the parasite
reservoir through early diagnosis and treatment and use
of efficacious medicines. Based on GMP targets [7-9],
80% of individuals suffering from uncomplicated or
severe malaria should have access to and be able to use
correct, affordable, and appropriate treatment within 24
hours. The present study demonstrated that the majority
of both severe and uncomplicated malaria cases were
given appropriate and complete treatment in line with
national guideline. However, treatment was sought
within 24 to 48 hours for two-third of uncomplicated
and half of severe malaria cases which is far from the
80% target set by the RBM Partnership for 2010. Avail-
able documents from other parts of the world
[11-15,19-21], with an exception for Morogoro Region
(82.7%), have also shown that the proportion of patients
receiving an appropriate anti-malarial timely and cor-
rectly-dosed were low and too far from the RBM targets
for 2010.
Furthermore, data suggests striking differences in time
interval between onset of symptoms and lab diagnosis/
treatment of malaria patients across three surveyed pro-
vinces, which is consistent with the previous studies
[11-15,19-21]. Interestingly, individuals in urban areas
were more likely than those in rural areas to receive
anti-malarial drugs or receive treatment promptly
amongst the prior studies [11-15,19-21]. In contrast,
Figure 3 Malaria indicators at health facilities.
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malaria patients both uncomplicated and severe cases in
rural areas were more likely to receive medical attention
and take an anti-malarial drug within 24 to 48 hours of
disease onset in the current study. The reason for this
might be the attendance of health house in rural areas
with local staff and adequate supply and equipment,
which facilitate prompt diagnosis and treatment.
Prior studies [19] have also suggested that several fac-
tors related to the community and health system may
hinder access to prompt and effective treatment. The
community factors could be classified as cultural factors,
the people’s poor perceptions of quality of care, their
lack of trust in health providers, and their perception of
the effectiveness of drugs provided in government health
facilities. Health system factors comprised of drug avail-
ability, provider practices such as careless of health
workers in prescribing appropriate anti-malarial or
doses to patients.
On the other hand, an interventional study in Tanza-
nia [22] illustrated that improving understanding and
treatment of malaria could lead to tangible improve-
ments in terms of people’s perception and actions for
the treatment of malaria. Therefore, the Ministry of
Health in Iran should invest adequately in above-men-
tioned mechanisms that may promote access to effective
treatment.
Furthermore, the operational classification of malaria
foci is one of the key components of GMP at the stage
of malaria elimination. The transition of the functional
status of malaria focus depending on the local situation
and it might change constantly. According to the WHO
classification [8], four categories of malaria foci are
recognized including residual non-active; residual active;
new potential and new active. Therefore, the status of
every malaria focus must be reviewed on the quarterly
basis and re-categorized when necessary. Consequently,
the national malaria programme of Iran has also
adopted this strategy during the past several years. How-
ever, the present study revealed that only one-third of
target districts in Iran had updated inventory of malaria
foci in accordance to the GMP.
Moreover, the centre for disease control and preven-
tion in Iran aims to detect malaria epidemics (a majority
of them are due to vivax malaria) within one week of
onset and control them in less than a month, as advised
by RBM programme [7-9]. Approximately, all the
malaria epidemics with the available data in target dis-
tricts detected within one week of onset by health staff,
which is in line with GMP (80%). However, only half of
them were controlled within four weeks of detection,
which is lower than RBM/GMP goal. A recent review of
epidemics in Africa [23] has also revealed delays in both
epidemic detection and response up to 20 weeks, basi-
cally, due to poor case reporting and analysis or low use
of public facilities. According to this study, epidemic
controls were deficient and epidemic lasted between 15
- 36 weeks.
In comparison, Coleman et al [24] examined a three-
tier malaria outbreak identification system using histori-
cal binomial thresholds to prompt early outbreak detec-
tion and response in South Africa. With this system,
100% health facilities reported outbreaks within 72
hours and appropriate response to all malaria outbreaks
were achieved within 24 hours. Importantly, the bino-
mial exact thresholds produced only one false weekly
outbreak compared to 9 to 12 false weekly outbreaks by
other recommended statistical approaches (i.e. mean + 2
SD) in the same study. These contradictions revealed
the fact that malaria epidemics are multifactorial and
difficult to predict correctly and timely only with the
current advised methods. Therefore, research is needed
to examine different methods for early identification of
malaria outbreaks based on all relevant data, which in
turn could facilitate timely response to epidemics.
Furthermore, health centres have proposed to assign
and equip some of their health facilities with adequate
supply (i.e. spray pumps, thermal fogger machine both
portable and vehicle mounted, insecticides for indoor
residual spraying, insecticide for space spraying, insecti-
cide-treated nets, anti-malarial drugs, rapid diagnostic
tests, lancet, plain slide, alcohol pad, cotton, slide box,
stationery) for emergency situation such as outbreaks.
The current findings showed that less than half of
sampled health centres had at least one assigned small
emergency site with adequate supply and equipment
stock to be used in outbreak. Importantly, there was
inconsistency in assignment of emergency sites across
three provinces. Therefore, the present study indicates
shortage and inconsistency in management and evalua-
tion of malaria foci, detection and control of malaria
epidemics as well as assignment of emergency sites
across different regions of Iran.
Conclusion
In conclusion, massive and substantial investments are
needed to coordinate national malaria control pro-
grammes in Iran towards achieving determined goals
and targets set by WHO. The first requirement is
improving the quality of malaria case management. Sec-
ondly, health policy makers have to strength the epi-
demic preparedness and response capacity at the
national level. More importantly, Ministry of Health
should be ensured about the availability of nationally
recommended anti-malarial drugs as well as other
equipments stocks in all health facilities.
The national malaria control programme of Iran
should also put an emphasis on robustness and active-
ness of surveillance systems coupled with vigorous
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community recruitment as the driving force to ensure
increased access to treatment. Finally, future research
should focus on examination of health worker practices
regarding case management as well as epidemic identifi-
cation and response.
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